Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Assets
Current assets
Cash and cash equivalents
Short-term restricted cash
Short-term investments
Account receivables, net
Short-term deposits
Marketable securities
Trade receivables, net
Other receivables and prepaid expenses
Total current assets
Non-current assets
Other long-term assets
Property and equipment, net
Operating lease right-of-use assets, net
Intangible assets, net
Goodwill
Total non-current assets
Total assets
Liabilities and Shareholders' Equity
Current liabilities
Account payables
Other payables and accrued expenses
Deferred revenue
Warrants for redeemable convertible preferred shares
Current portion of operating lease liabilities
Current portion of contingent consideration
Total current liabilities
Non-Current liabilities
Warrants for ordinary shares
Operating lease liabilities, less current portion
Contingent consideration, less current portion
Other non-current liabilities
Total non-current liabilities
Total liabilities
Redeemable convertible preferred shares, no par value; 0 and 71,463,499 shares authorized as at December 31, 2021 and 2020, respectively; 0 and 62,926,410 shares issued and outstanding as at December 31, 2021 and 2020, respectively;
Shareholders’ equity:
Ordinary shares, no par value; 450,000,000 shares authorized as of December 31, 2022, and 2021; 141,880,227 and 132,214,733 shares issued and outstanding as of December 31, 2022 and 2021, respectively;
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity
Total liabilities and Shareholders’ Equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support